A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment
Clinical trial NCT04241549 · COMPLETED
Trial details
- NCT number
- NCT04241549
- Sponsor
- OncoVerity, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-25
- Primary completion
- 2021-07-19
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.